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background: Cardioversion (CV) is a class I indicated procedure for symptomatic atrial fibrillation (AF). There are few contemporary reports on CV 
practices or outcomes in a purely US population.
methods: Using the nationwide prospective ORBIT AF registry, we analyzed the use of CV and compared patient characteristics, AF progression, and 
unadjusted cardiovascular outcomes for patients with and without CV. AF progression was defined as change from paroxysmal to persistent AF or 
change from paroxysmal or persistent to permanent AF.
results: Among 9,642 patients, 817 patients (8.5%) underwent 1,052 CVs during a median follow-up of 12 months. The majority (84%) of the CVs 
were direct current (DC) and a minority (16%) were pharmacologic. Transesophageal echocardiography (TEE) was used in 188 (18%) CVs with nearly 
all (97%) being DC CVs. Patients undergoing CV were more frequently younger, in persistent AF, and have sleep apnea. Patients undergoing CV had 
11 strokes (1.2 per 100 patient years) and 254 cardiovascular hospitalizations (36.1 per 100 patient years) during follow-up (Table 1). Unadjusted 
progression of AF was seen in 21% of patients after their first CV, as compared with 17% of non-permanent, non-cardioverted AF patients.
conclusions: CV is frequently used in patients with AF but less than 2 in 10 CVs are TEE guided. Strokes are uncommon after CV in clinical 
practice, but cardiovascular hospitalizations are frequent. We observed similar unadjusted rates of AF progression in CV and non-CV patients.
Cardioverted (N=817) Overall (N=9642)
Unadjusted Outcome Events (events per 100 patient-years) Events (events per 100 patient-years)
All-cause Death 29 (3.13) 879 (5.42)
Revascularization 17 (1.86) 227 (1.42)
MI 11 (1.20) 127 (0.79)
New-Onset/HF Diagnosis 18 (1.97) 299 (1.87)
Stroke or Non-CNS embolism 11 (1.19) 169 (1.05)
TIA 4 (0.43) 105 (0.65)
1st Hospitalization (All-cause) 329 (51.34) 4329 (36.37)
1st Bleeding Hospitalization 24 (2.63) 537 (3.41)
1st Cardiovascular Hospitalization 254 (36.14) 2488 (18.09)
Major bleeding 32 (3.53) 619 (3.94)
